fiercepharmamanufacturing.com
Description: Fierce Pharma Manufacturing. Here's the most recent news related to Manufacturing.
  • Google PR 6
    Trustworthiness Good
  • Avg. Daily Visitors N/A
    Child Safety Unknown
  • Avg. Daily Pageviews N/A
    Privacy Good

Manufacturing | FiercePharma

Fiercepharmamanufacturing.com: get to the top rated Fierce Pharma Manufacturing pages and content popular with USA-based Fiercepharmamanufacturing.com users or check the following digest to find out more. Fiercepharmamanufacturing.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Fierce Pharma Manufacturing team are just starting to conquer the social media and they have already achieved a promising result — 2 user activities so far (LinkedIn dominates with around 95% of all user reactions). Fiercepharmamanufacturing.com is hosted with CloudFlare, Inc. in United States. Fierce Pharma Manufacturing traffic is not yet estimated by Alexa.
Visit fiercepharmamanufacturing.com

Domain info

Location: United States
Registrant: Domain Administrator (Questex LLC)
Hosted by: CloudFlare, Inc.
Registrar: Nom-iq Ltd. dba COM LAUDE
Subnetworks: 104.21.26.105, 172.67.135.222

Alexa's Traffic Estimates & Trends

Traffic Rank: 762 935
More details from Alexa

Social Media Activities

  • Facebook likes: -
  • Twitter mentions: -
  • Google pluses: -
  • LinkedIn mentions: 2
  • Pinterest pins: -
  • StumbleUpon views: -

Web Safety

  • This website is malware-free.
  • Status ok
See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Fiercepharmamanufacturing.com popular pages to visit

U.K. building $85M cell therapy manufacturing operation | FiercePharma The Cell Therapy Catapult is part of a government program created a couple of years ago to pump up the cell therapy industry in the U.K. The group plans to invest more than $85 million to build a larg...
Manufacturing | FiercePharma Here's the most recent news related to Manufacturing
Tracking troubles stalled recall | FiercePharma Although noncompliance with good manufacturing practices led to the contamination of heparin injections from late 2007 to early 2008, an inability to cope with supply chain complexities is to blame

Other websites we recently analyzed